Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Fintepla 2.2 mg/mL oral solution {equilateral_black_triangle}

Active Ingredient:
fenfluramine hydrochloride
Company:  
UCB Pharma Limited See contact details
ATC code: 
N03AX26
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Fintepla Patients and Caregivers alert card

Important information about Fintepla® for Patients and Caregivers in the United Kingdom.

{pdf_link}

Fintepla Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Guide for Prescribers in the United Kingdom on reducing the risks related to medicines and their administration.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

UCB Pharma Limited
Company image
Address
208 Bath Road, Slough, Berkshire, SL1 3WE
Medical Information Direct Line
+44 (0) 1753 777 100
Medical Information e-mail
[email protected]
Telephone
+ 44 (0) 1753 534655